LAMEA Interventional Oncology Market

LAMEA Interventional Oncology Market Size, Share & Industry Trends Analysis Report By Cancer Type (Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis), By Product Type, By End User, By Country and Growth Forecast, 2022 - 2028

Report Id: KBV-9709 Publication Date: June-2022 Number of Pages: 98
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Market Report Description

The Latin America, Middle East and Africa Interventional Oncology Market would witness market growth of 9.9% CAGR during the forecast period (2022-2028).

IO has proven to be especially effective in the treatment of pain in cancer patients, the huge majority of whom are unable to get enough relief from pain medications and radiotherapy. About 90% of cancer patients experience pain during their treatment, and nearly half of those with advanced cancer experience mild to severe pain. Minimally invasive IO procedures such as ablation, neurolysis, bone and vertebral augmentation are all effective palliative treatments for cancer pain. These treatments act on the tumour directly or indirectly, as in the case of regional anaesthesia from neurolysis, by limiting its growth and stabilising the lesion.

The United Arab Emirates (UAE) has one of the quicker economies in the world, which has resulted in a rise in noncommunicable diseases such as cancer. Although screening and early diagnosis efforts that seem to be far from objective coverage of the targeted respondents, the number of cases and death have been rising in the UAE over the years. The UAE's cancer control plan is being developed in accordance with WHO and EMRO guidelines, with specific objectives and goals in mind. The goals are to fight cancer, reduce its occurrence, control mortality, and enhance cancer patients' outcomes and quality of life. Improved public health education, early detection, prevention, fast diagnosis, continuity of care, treatment facilitation, workforce training, performance evaluation, and research are also priorities.

After cardiovascular illnesses and trauma, cancer is the third largest cause of mortality in the United Arab Emirates (UAE). The death ratio in the United Arab Emirates is 0.39, which is similar to other developed nations. Owing to the rise in the case of cancer, the regional interventional oncology market would augment in the forecast period.

The Brazil market dominated the LAMEA Interventional Oncology Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $51.3 million by 2028. The Argentina market is experiencing a CAGR of 10.4% during (2022 - 2028). Additionally, The UAE market would exhibit a CAGR of 9.6% during (2022 - 2028).

Based on Cancer Type, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Metastasis, and Others. Based on Product Type, the market is segmented into Embolization Devices, Ablation Devices, and Support Devices. Based on End User, the market is segmented into Hospitals, Ambulatory Surgery Centers, and Research & Academic Institutes. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Interventional Oncology Market is Predict to reach $2.9 Billion by 2028, at a CAGR of 6.2%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, Teleflex, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Terumo Corporation , Johnson & Johnson (Johnson & Johnson Services, Inc.), Becton, Dickinson and Company, AngioDynamics, Inc., Merit Medical Systems, Inc., and HealthTronics, Inc. (Altaris Capital Partners, LLC)

Scope of the Study

Market Segments Covered in the Report:

By Cancer Type

  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Breast Cancer
  • Prostate Cancer
  • Bone Metastasis
  • Others

By Product Type

  • Embolization Devices
  • Ablation Devices
  • Support Devices

By End User

  • Hospitals
  • Ambulatory Surgery Centers
  • Research & Academic Institutes

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Boston Scientific Corporation
  • Teleflex, Inc.
  • Cook Medical, Inc. (Cook Group)
  • Medtronic PLC
  • Terumo Corporation
  • Johnson & Johnson (Johnson & Johnson Services, Inc.)
  • Becton, Dickinson and Company
  • AngioDynamics, Inc.
  • Merit Medical Systems, Inc.
  • HealthTronics, Inc. (Altaris Capital Partners, LLC)
Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now


Call: +1(646) 600-5072


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo